Table of Content

1 Animal Rabies Vaccine Market Overview
1.1 Product Overview and Scope of Animal Rabies Vaccine
1.2 Animal Rabies Vaccine Segment by Type
1.2.1 Global Animal Rabies Vaccine Sales Growth Rate Comparison by Type (2021-2027)
1.2.2 Inject Vaccine
1.2.3 Oral Vaccine
1.3 Animal Rabies Vaccine Segment by Application
1.3.1 Animal Rabies Vaccine Sales Comparison by Application: (2021-2027)
1.3.2 Pet
1.3.3 Wild Animals
1.4 Global Animal Rabies Vaccine Market Size Estimates and Forecasts
1.4.1 Global Animal Rabies Vaccine Revenue 2016-2027
1.4.2 Global Animal Rabies Vaccine Sales 2016-2027
1.4.3 Animal Rabies Vaccine Market Size by Region: 2016 Versus 2021 Versus 2027

2 Animal Rabies Vaccine Market Competition by Manufacturers
2.1 Global Animal Rabies Vaccine Sales Market Share by Manufacturers (2016-2021)
2.2 Global Animal Rabies Vaccine Revenue Market Share by Manufacturers (2016-2021)
2.3 Global Animal Rabies Vaccine Average Price by Manufacturers (2016-2021)
2.4 Manufacturers Animal Rabies Vaccine Manufacturing Sites, Area Served, Product Type
2.5 Animal Rabies Vaccine Market Competitive Situation and Trends
2.5.1 Animal Rabies Vaccine Market Concentration Rate
2.5.2 The Global Top 5 and Top 10 Largest Animal Rabies Vaccine Players Market Share by Revenue
2.5.3 Global Animal Rabies Vaccine Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.6 Manufacturers Mergers & Acquisitions, Expansion Plans

3 Animal Rabies Vaccine Retrospective Market Scenario by Region
3.1 Global Animal Rabies Vaccine Retrospective Market Scenario in Revenue by Region: 2016-2021
3.2 Global Animal Rabies Vaccine Retrospective Market Scenario in Sales by Region: 2016-2021
3.3 North America Animal Rabies Vaccine Market Facts & Figures by Country
3.3.1 North America Animal Rabies Vaccine Sales by Country
3.3.2 North America Animal Rabies Vaccine Revenue by Country
3.3.3 U.S.
3.3.4 Canada
3.4 Europe Animal Rabies Vaccine Market Facts & Figures by Country
3.4.1 Europe Animal Rabies Vaccine Sales by Country
3.4.2 Europe Animal Rabies Vaccine Revenue by Country
3.4.3 Germany
3.4.4 France
3.4.5 U.K.
3.4.6 Italy
3.4.7 Russia
3.5 Asia Pacific Animal Rabies Vaccine Market Facts & Figures by Region
3.5.1 Asia Pacific Animal Rabies Vaccine Sales by Region
3.5.2 Asia Pacific Animal Rabies Vaccine Revenue by Region
3.5.3 China
3.5.4 Japan
3.5.5 South Korea
3.5.6 India
3.5.7 Australia
3.5.8 Taiwan
3.5.9 Indonesia
3.5.10 Thailand
3.5.11 Malaysia
3.5.12 Philippines
3.5.13 Vietnam
3.6 Latin America Animal Rabies Vaccine Market Facts & Figures by Country
3.6.1 Latin America Animal Rabies Vaccine Sales by Country
3.6.2 Latin America Animal Rabies Vaccine Revenue by Country
3.6.3 Mexico
3.6.4 Brazil
3.6.5 Argentina
3.7 Middle East and Africa Animal Rabies Vaccine Market Facts & Figures by Country
3.7.1 Middle East and Africa Animal Rabies Vaccine Sales by Country
3.7.2 Middle East and Africa Animal Rabies Vaccine Revenue by Country
3.7.3 Turkey
3.7.4 Saudi Arabia
3.7.5 UAE
4 Global Animal Rabies Vaccine Historic Market Analysis by Type
4.1 Global Animal Rabies Vaccine Sales Market Share by Type (2016-2021)
4.2 Global Animal Rabies Vaccine Revenue Market Share by Type (2016-2021)
4.3 Global Animal Rabies Vaccine Price by Type (2016-2021)

5 Global Animal Rabies Vaccine Historic Market Analysis by Application
5.1 Global Animal Rabies Vaccine Sales Market Share by Application (2016-2021)
5.2 Global Animal Rabies Vaccine Revenue Market Share by Application (2016-2021)
5.3 Global Animal Rabies Vaccine Price by Application (2016-2021)

6 Key Companies Profiled
6.1 Fort Dodge
6.1.1 Fort Dodge Corporation Information
6.1.2 Fort Dodge Description and Business Overview
6.1.3 Fort Dodge Animal Rabies Vaccine Sales, Revenue and Gross Margin (2016-2021)
6.1.4 Fort Dodge Product Portfolio
6.1.5 Fort Dodge Recent Developments/Updates
6.2 Boehringer Ingelheim
6.2.1 Boehringer Ingelheim Corporation Information
6.2.2 Boehringer Ingelheim Description and Business Overview
6.2.3 Boehringer Ingelheim Animal Rabies Vaccine Sales, Revenue and Gross Margin (2016-2021)
6.2.4 Boehringer Ingelheim Product Portfolio
6.2.5 Boehringer Ingelheim Recent Developments/Updates
6.3 Pfizer
6.3.1 Pfizer Corporation Information
6.3.2 Pfizer Description and Business Overview
6.3.3 Pfizer Animal Rabies Vaccine Sales, Revenue and Gross Margin (2016-2021)
6.3.4 Pfizer Product Portfolio
6.3.5 Pfizer Recent Developments/Updates
6.4 CE-VA
6.4.1 CE-VA Corporation Information
6.4.2 CE-VA Description and Business Overview
6.4.3 CE-VA Animal Rabies Vaccine Sales, Revenue and Gross Margin (2016-2021)
6.4.4 CE-VA Product Portfolio
6.4.5 CE-VA Recent Developments/Updates
6.5 Virbac
6.5.1 Virbac Corporation Information
6.5.2 Virbac Description and Business Overview
6.5.3 Virbac Animal Rabies Vaccine Sales, Revenue and Gross Margin (2016-2021)
6.5.4 Virbac Product Portfolio
6.5.5 Virbac Recent Developments/Updates
6.6 Schering-Plough
6.6.1 Schering-Plough Corporation Information
6.6.2 Schering-Plough Description and Business Overview
6.6.3 Schering-Plough Animal Rabies Vaccine Sales, Revenue and Gross Margin (2016-2021)
6.6.4 Schering-Plough Product Portfolio
6.6.5 Schering-Plough Recent Developments/Updates
6.7 Bayer
6.6.1 Bayer Corporation Information
6.6.2 Bayer Description and Business Overview
6.6.3 Bayer Animal Rabies Vaccine Sales, Revenue and Gross Margin (2016-2021)
6.4.4 Bayer Product Portfolio
6.7.5 Bayer Recent Developments/Updates
6.8 Merck
6.8.1 Merck Corporation Information
6.8.2 Merck Description and Business Overview
6.8.3 Merck Animal Rabies Vaccine Sales, Revenue and Gross Margin (2016-2021)
6.8.4 Merck Product Portfolio
6.8.5 Merck Recent Developments/Updates
6.9 Novartis
6.9.1 Novartis Corporation Information
6.9.2 Novartis Description and Business Overview
6.9.3 Novartis Animal Rabies Vaccine Sales, Revenue and Gross Margin (2016-2021)
6.9.4 Novartis Product Portfolio
6.9.5 Novartis Recent Developments/Updates

7 Animal Rabies Vaccine Manufacturing Cost Analysis
7.1 Animal Rabies Vaccine Key Raw Materials Analysis
7.1.1 Key Raw Materials
7.1.2 Key Suppliers of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
7.3 Manufacturing Process Analysis of Animal Rabies Vaccine
7.4 Animal Rabies Vaccine Industrial Chain Analysis

8 Marketing Channel, Distributors and Customers
8.1 Marketing Channel
8.2 Animal Rabies Vaccine Distributors List
8.3 Animal Rabies Vaccine Customers

9 Animal Rabies Vaccine Market Dynamics
9.1 Animal Rabies Vaccine Industry Trends
9.2 Animal Rabies Vaccine Growth Drivers
9.3 Animal Rabies Vaccine Market Challenges
9.4 Animal Rabies Vaccine Market Restraints

10 Global Market Forecast
10.1 Animal Rabies Vaccine Market Estimates and Projections by Type
10.1.1 Global Forecasted Sales of Animal Rabies Vaccine by Type (2022-2027)
10.1.2 Global Forecasted Revenue of Animal Rabies Vaccine by Type (2022-2027)
10.2 Animal Rabies Vaccine Market Estimates and Projections by Application
10.2.1 Global Forecasted Sales of Animal Rabies Vaccine by Application (2022-2027)
10.2.2 Global Forecasted Revenue of Animal Rabies Vaccine by Application (2022-2027)
10.3 Animal Rabies Vaccine Market Estimates and Projections by Region
10.3.1 Global Forecasted Sales of Animal Rabies Vaccine by Region (2022-2027)
10.3.2 Global Forecasted Revenue of Animal Rabies Vaccine by Region (2022-2027)

11 Research Finding and Conclusion

12 Methodology and Data Source
12.1 Methodology/Research Approach
12.1.1 Research Programs/Design
12.1.2 Market Size Estimation
12.1.3 Market Breakdown and Data Triangulation
12.2 Data Source
12.2.1 Secondary Sources
12.2.2 Primary Sources
12.3 Author List
12.4 Disclaimer

List of Figure

List of Tables
Table 1. Global Animal Rabies Vaccine Sales (K Units) Growth Rate Comparison by Type (2021-2027)
Table 2. Global Animal Rabies Vaccine Sales (K Units) Comparison by Application (2021-2027)
Table 3. Global Animal Rabies Vaccine Market Size by Region (US$ Million) (2016 VS 2021 VS 2027)
Table 4. Key Manufacturers Animal Rabies Vaccine Covered in This Study
Table 5. Global Animal Rabies Vaccine Sales (K Units) of Key Manufacturers (2016-2021)
Table 6. Global Animal Rabies Vaccine Sales Share by Manufacturers (2016-2021)
Table 7. Global Animal Rabies Vaccine Revenue (US$ Million) by Manufacturers (2016-2021)
Table 8. Global Animal Rabies Vaccine Revenue Share by Manufacturers (2016-2021)
Table 9. Global Market Animal Rabies Vaccine Average Price (US$/Unit) of Key Manufacturers (2016-2021)
Table 10. Manufacturers Animal Rabies Vaccine Manufacturing Sites and Area Served
Table 11. Manufacturers Animal Rabies Vaccine Product Type
Table 12. Global Animal Rabies Vaccine Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 13. Global Animal Rabies Vaccine by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Animal Rabies Vaccine as of 2020)
Table 14. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 15. Global Animal Rabies Vaccine Sales by Region (2016-2021) & (K Units)
Table 16. Global Animal Rabies Vaccine Sales Market Share by Region (2016-2021)
Table 17. Global Animal Rabies Vaccine Revenue by Region (2016-2021) & (US$ Million)
Table 18. North America Animal Rabies Vaccine Sales by Country (2016-2021) & (K Units)
Table 19. North America Animal Rabies Vaccine Sales Market Share by Country (2016-2021)
Table 20. North America Animal Rabies Vaccine Revenue by Country (2016-2021) & (US$ Million)
Table 21. North America Animal Rabies Vaccine Revenue Market Share by Country (2016-2021)
Table 22. Europe Animal Rabies Vaccine Sales by Country (2016-2021) & (K Units)
Table 23. Europe Animal Rabies Vaccine Sales Market Share by Country (2016-2021)
Table 24. Europe Animal Rabies Vaccine Revenue by Country (2016-2021) & (US$ Million)
Table 25. Europe Animal Rabies Vaccine Revenue Market Share by Country (2016-2021)
Table 26. Asia Pacific Animal Rabies Vaccine Sales by Region (2016-2021) & (K Units)
Table 27. Asia Pacific Animal Rabies Vaccine Sales Market Share by Region (2016-2021)
Table 28. Asia Pacific Animal Rabies Vaccine Revenue by Region (2016-2021) & (US$ Million)
Table 29. Asia Pacific Animal Rabies Vaccine Revenue Market Share by Region (2016-2021)
Table 30. Latin America Animal Rabies Vaccine Sales by Country (2016-2021) & (K Units)
Table 31. Latin America Animal Rabies Vaccine Sales Market Share by Country (2016-2021)
Table 32. Latin America Animal Rabies Vaccine Revenue by Country (2016-2021) & (US$ Million)
Table 33. Latin America Animal Rabies Vaccine Revenue Market Share by Country (2016-2021)
Table 34. Middle East and Africa Animal Rabies Vaccine Sales by Country (2016-2021) & (K Units)
Table 35. Middle East and Africa Animal Rabies Vaccine Sales Market Share by Country (2016-2021)
Table 36. Middle East and Africa Animal Rabies Vaccine Revenue by Country (2016-2021) & (US$ Million)
Table 37. Middle East and Africa Animal Rabies Vaccine Revenue Market Share by Country (2016-2021)
Table 38. Global Animal Rabies Vaccine Sales (K Units) by Type (2016-2021)
Table 39. Global Animal Rabies Vaccine Sales Market Share by Type (2016-2021)
Table 40. Global Animal Rabies Vaccine Revenue (Million US$) by Type (2016-2021)
Table 41. Global Animal Rabies Vaccine Revenue Share by Type (2016-2021)
Table 42. Global Animal Rabies Vaccine Price (US$/Unit) by Type (2016-2021)
Table 43. Global Animal Rabies Vaccine Sales (K Units) by Application (2016-2021)
Table 44. Global Animal Rabies Vaccine Sales Market Share by Application (2016-2021)
Table 45. Global Animal Rabies Vaccine Revenue (Million US$) by Application (2016-2021)
Table 46. Global Animal Rabies Vaccine Revenue Share by Application (2016-2021)
Table 47. Global Animal Rabies Vaccine Price (US$/Unit) by Application (2016-2021)
Table 48. Fort Dodge Corporation Information
Table 49. Fort Dodge Description and Business Overview
Table 50. Fort Dodge Animal Rabies Vaccine Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2016-2021)
Table 51. Fort Dodge Animal Rabies Vaccine Product
Table 52. Fort Dodge Recent Developments/Updates
Table 53. Boehringer Ingelheim Corporation Information
Table 54. Boehringer Ingelheim Description and Business Overview
Table 55. Boehringer Ingelheim Animal Rabies Vaccine Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2016-2021)
Table 56. Boehringer Ingelheim Animal Rabies Vaccine Product
Table 57. Boehringer Ingelheim Recent Developments/Updates
Table 58. Pfizer Corporation Information
Table 59. Pfizer Description and Business Overview
Table 60. Pfizer Animal Rabies Vaccine Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2016-2021)
Table 61. Pfizer Animal Rabies Vaccine Product
Table 62. Pfizer Recent Developments/Updates
Table 63. CE-VA Corporation Information
Table 64. CE-VA Description and Business Overview
Table 65. CE-VA Animal Rabies Vaccine Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2016-2021)
Table 66. CE-VA Animal Rabies Vaccine Product
Table 67. CE-VA Recent Developments/Updates
Table 68. Virbac Corporation Information
Table 69. Virbac Description and Business Overview
Table 70. Virbac Animal Rabies Vaccine Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2016-2021)
Table 71. Virbac Animal Rabies Vaccine Product
Table 72. Virbac Recent Developments/Updates
Table 73. Schering-Plough Corporation Information
Table 74. Schering-Plough Description and Business Overview
Table 75. Schering-Plough Animal Rabies Vaccine Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2016-2021)
Table 76. Schering-Plough Animal Rabies Vaccine Product
Table 77. Schering-Plough Recent Developments/Updates
Table 78. Bayer Corporation Information
Table 79. Bayer Description and Business Overview
Table 80. Bayer Animal Rabies Vaccine Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2016-2021)
Table 81. Bayer Animal Rabies Vaccine Product
Table 82. Bayer Recent Developments/Updates
Table 83. Merck Corporation Information
Table 84. Merck Description and Business Overview
Table 85. Merck Animal Rabies Vaccine Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2016-2021)
Table 86. Merck Animal Rabies Vaccine Product
Table 87. Merck Recent Developments/Updates
Table 88. Novartis Corporation Information
Table 89. Novartis Description and Business Overview
Table 90. Novartis Animal Rabies Vaccine Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2016-2021)
Table 91. Novartis Animal Rabies Vaccine Product
Table 92. Novartis Recent Developments/Updates
Table 93. Production Base and Market Concentration Rate of Raw Material
Table 94. Key Suppliers of Raw Materials
Table 95. Animal Rabies Vaccine Distributors List
Table 96. Animal Rabies Vaccine Customers List
Table 97. Animal Rabies Vaccine Market Trends
Table 98. Animal Rabies Vaccine Growth Drivers
Table 99. Animal Rabies Vaccine Market Restraints
Table 100. Global Animal Rabies Vaccine Sales Forecast by Type (2022-2027) & (K Units)
Table 101. Global Animal Rabies Vaccine Sales Market Share Forecast by Type (2022-2027)
Table 102. Global Animal Rabies Vaccine Revenue Forecast by Type (2022-2027) & (US$ Million)
Table 103. Global Animal Rabies Vaccine Revenue Market Share Forecast by Type (2022-2027)
Table 104. Global Animal Rabies Vaccine Sales Forecast by Application (2022-2027) & (K Units)
Table 105. Global Animal Rabies Vaccine Sales Market Share Forecast by Application (2022-2027)
Table 106. Global Animal Rabies Vaccine Revenue Forecast by Application (2022-2027) & (US$ Million)
Table 107. Global Animal Rabies Vaccine Revenue Market Share Forecast by Application (2022-2027)
Table 108. Global Animal Rabies Vaccine Sales Forecast by Region (2022-2027) & (K Units)
Table 109. Global Animal Rabies Vaccine Sales Market Share Forecast by Region (2022-2027)
Table 110. Global Animal Rabies Vaccine Revenue Forecast by Region (2022-2027) & (US$ Million)
Table 111. Global Animal Rabies Vaccine Revenue Market Share Forecast by Region (2022-2027)
Table 112. Research Programs/Design for This Report
Table 113. Key Data Information from Secondary Sources
Table 114. Key Data Information from Primary Sources
List of Figures
Figure 1. Product Picture of Animal Rabies Vaccine
Figure 2. Global Animal Rabies Vaccine Market Share by Type in 2020 & 2027
Figure 3. Inject Vaccine Product Picture
Figure 4. Oral Vaccine Product Picture
Figure 5. Global Animal Rabies Vaccine Market Share by Application in 2020 & 2027
Figure 6. Pet
Figure 7. Wild Animals
Figure 8. Global Animal Rabies Vaccine Revenue, (US$ Million), 2016 VS 2021 VS 2027
Figure 9. Global Animal Rabies Vaccine Market Size 2016-2027 (US$ Million)
Figure 10. Global Animal Rabies Vaccine Sales 2016-2027 (K Units)
Figure 11. Global Animal Rabies Vaccine Market Size Market Share by Region: 2016 VS 20210 VS 2027
Figure 12. Animal Rabies Vaccine Sales Share by Manufacturers in 2020
Figure 13. Global Animal Rabies Vaccine Revenue Share by Manufacturers in 2020
Figure 14. The Global 5 and 10 Largest Animal Rabies Vaccine Players: Market Share by Revenue in 2020
Figure 15. Animal Rabies Vaccine Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2016 VS 2021
Figure 16. Global Animal Rabies Vaccine Sales Market Share by Region (2016-2021)
Figure 17. Global Animal Rabies Vaccine Sales Market Share by Region in 2020
Figure 18. Global Animal Rabies Vaccine Revenue Market Share by Region (2016-2021)
Figure 19. Global Animal Rabies Vaccine Revenue Market Share by Region in 2020
Figure 20. U.S. Animal Rabies Vaccine Revenue Growth Rate (2016-2021) (US$ Million)
Figure 21. Canada Animal Rabies Vaccine Revenue Growth Rate (2016-2021) (US$ Million)
Figure 22. Germany Animal Rabies Vaccine Revenue Growth Rate (2016-2021) (US$ Million)
Figure 23. France Animal Rabies Vaccine Revenue Growth Rate (2016-2021) (US$ Million)
Figure 24. U.K. Animal Rabies Vaccine Revenue Growth Rate (2016-2021) (US$ Million)
Figure 25. Italy Animal Rabies Vaccine Revenue Growth Rate (2016-2021) (US$ Million)
Figure 26. Russia Animal Rabies Vaccine Revenue Growth Rate (2016-2021) (US$ Million)
Figure 27. China Animal Rabies Vaccine Revenue Growth Rate (2016-2021) (US$ Million)
Figure 28. Japan Animal Rabies Vaccine Revenue Growth Rate (2016-2021) (US$ Million)
Figure 29. South Korea Animal Rabies Vaccine Revenue Growth Rate (2016-2021) (US$ Million)
Figure 30. India Animal Rabies Vaccine Revenue Growth Rate (2016-2021) (US$ Million)
Figure 31. Australia Animal Rabies Vaccine Revenue Growth Rate (2016-2021) (US$ Million)
Figure 32. Taiwan Animal Rabies Vaccine Revenue Growth Rate (2016-2021) (US$ Million)
Figure 33. Indonesia Animal Rabies Vaccine Revenue Growth Rate (2016-2021) (US$ Million)
Figure 34. Thailand Animal Rabies Vaccine Revenue Growth Rate (2016-2021) (US$ Million)
Figure 35. Malaysia Animal Rabies Vaccine Revenue Growth Rate (2016-2021) (US$ Million)
Figure 36. Philippines Animal Rabies Vaccine Revenue Growth Rate (2016-2021) (US$ Million)
Figure 37. Vietnam Animal Rabies Vaccine Revenue Growth Rate (2016-2021) (US$ Million)
Figure 38. Mexico Animal Rabies Vaccine Revenue Growth Rate (2016-2021) (US$ Million)
Figure 39. Brazil Animal Rabies Vaccine Revenue Growth Rate (2016-2021) (US$ Million)
Figure 40. Argentina Animal Rabies Vaccine Revenue Growth Rate (2016-2021) (US$ Million)
Figure 41. Turkey Animal Rabies Vaccine Revenue Growth Rate (2016-2021) (US$ Million)
Figure 42. Saudi Arabia Animal Rabies Vaccine Revenue Growth Rate (2016-2021) (US$ Million)
Figure 43. UAE Animal Rabies Vaccine Revenue Growth Rate (2016-2021) (US$ Million)
Figure 44. Sales Market Share of Animal Rabies Vaccine by Type (2016-2021)
Figure 45. Sales Market Share of Animal Rabies Vaccine by Application (2016-2021)
Figure 46. Sales Market Share of Animal Rabies Vaccine by Application in 2020
Figure 47. Revenue Share of Animal Rabies Vaccine by Application (2016-2021)
Figure 48. Revenue Share of Animal Rabies Vaccine by Application in 2020
Figure 49. Manufacturing Cost Structure of Animal Rabies Vaccine
Figure 50. Manufacturing Process Analysis of Animal Rabies Vaccine
Figure 51. Animal Rabies Vaccine Industrial Chain Analysis
Figure 52. Channels of Distribution
Figure 53. Distributors Profiles
Figure 54. Bottom-up and Top-down Approaches for This Report
Figure 55. Data Triangulation
Figure 56. Key Executives Interviewed